If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPrudential Regulatory News (PRU)

Share Price Information for Prudential (PRU)

Share Price is delayed by 15 minutes
Get Live Data
1,041.00    15.50 (1.51%)
Bid:
1,045.00
Ask:
1,045.50
Spread: 0.50 (0.048%)
Market Cap: £25.97b
PRU Live PriceLast checked at - London Stock Exchange

Intraday Prudential Share Chart

Repurchase to neutralise share issuances

15 Dec 2025 07:00

RNS Number : 4676L
Prudential PLC
15 December 2025
 

Prudential plc

 

Repurchase Programme to neutralise 2025 share issuances for scrip dividend

 

Prudential plc (the "Company") announces that it will commence a share repurchase programme in respect of c. 2,200,000[1] ordinary shares of 5 pence each ("Ordinary Shares"), in the issued share capital of the Company (the "Programme").

 

The purpose of the Programme is to reduce the issued share capital of the Company to offset dilution from shares issued under the scrip dividend alternative in respect of the 2024 second interim dividend and the 2025 first interim dividend of 16.29 and 7.71 US cents per Ordinary Share, respectively. Based on the total number of Ordinary Shares in issue announced on 12 December 2025, the Programme approximates to 0.09% of the Company's issued share capital. The Directors consider the Programme to be in the best interests of the Company and of its shareholders generally. Given its small size, the implementation of the Programme is expected to marginally enhance earnings per share.

 

The Company intends to make further repurchases of its Ordinary Shares in future including in order to offset issuances under the scrip dividend scheme (if offered) and any expected dilution from the vesting of awards under employee and agent share schemes. The Company will make further announcements in respect of any such repurchases in due course.

 

Detailed terms of the Programme

 

The Company has entered into an arrangement with Merrill Lynch International ("MLI") (acting as riskless principal) to conduct the repurchases in respect of the Programme on its behalf.

 

The arrangement with MLI enables the purchase of Ordinary Shares for a period from 15 December 2025, and will complete no later than 19 December 2025. The aggregate maximum pecuniary amount allocated to the Programme is GBP 31 million (exclusive of associated fees, expenses and stamp duty) (equivalent to HKD 322.2 million and USD 41.4 million, based on the closing exchange rate between USD and GBP and USD and HKD as of 12 December 2025 HKT).

 

MLI may effect purchases of Ordinary Shares under the Programme on the London Stock Exchange and/or other trading venues[2] for subsequent purchase by the Company. Purchases by the Company will be treated as on-exchange transactions subject to the Listing Rules of the London Stock Exchange and as on-market purchases for the purpose of the Hong Kong Code on Share Buy-Backs. .The Company intends that any Ordinary Shares purchased will be cancelled.

 

The Programme will run concurrently with the US$500 million third and final tranche of the Company's US$2 billion share buyback programme, announced on 1 July 2025 and also being conducted by MLI (acting as riskless principal).

 

The Programme is in accordance with the Company's general authority to purchase a maximum of 262,668,701 Ordinary Shares granted by shareholders at the Company's 2025 Annual General Meeting. The Programme will be conducted within the parameters prescribed by the Market Abuse Regulation 596/2014/EU (as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019), the Commission Delegated Regulation 2016/1052/EU (as in force in the UK and as amended by the FCA's Technical Standards (Market Abuse Regulation) (EU Exit) Instrument 2019) and in accordance with Chapter 9 of the UK Listing Rules, the Hong Kong Listing Rules and the Hong Kong Code on Share Buy-backs. No purchase of Ordinary Shares will be conducted on the Hong Kong Stock Exchange. No repurchases will be made in respect of the Company's American Depositary Receipts.

 

The Company will make further announcements in due course following any repurchase of shares. There is no guarantee that the Programme will be implemented in full or that any shares will be repurchased by the Company.

Additional information

About Prudential plc

Prudential provides life and health insurance and asset management in Greater China, ASEAN, India and Africa. Prudential's mission is to be the most trusted partner and protector for this generation and generations to come, by providing simple and accessible financial and health solutions. The business has dual primary listings on the Stock Exchange of Hong Kong (HKEX: 2378) and the London Stock Exchange (LSE: PRU). It also has a secondary listing on the Singapore Stock Exchange (SGX: K6S) and a listing on the New York Stock Exchange (NYSE: PUK) in the form of American Depositary Receipts. It is a constituent of the Hang Seng Composite Index and is also included for trading in the Shenzhen-Hong Kong Stock Connect programme and the Shanghai-Hong Kong Stock Connect programme.

 

Prudential is not affiliated in any manner with Prudential Financial, Inc. a company whose principal place of business is in the United States of America, nor with The Prudential Assurance Company Limited, a subsidiary of M&G plc, a company incorporated in the United Kingdom.

 

https://www.prudentialplc.com/

 

 

Contact

 

Media

Investors/Analysts

Simon Kutner

+44 (0)7581 023260

Patrick Bowes

+852 9611 2981

Sonia Tsang

+852 5580 7525

William Elderkin

+44 (0)20 3977 9215

Ming Hau

+44 20 3977 9293

Bosco Cheung

+852 2918 5499

Tianjiao Yu

+852 2918 5487

 


[1] Two million, one-hundred and ninety-seven-thousand, and six-hundred sixty-nine (2,197,669) Ordinary Shares

[2] Being any multilateral trading facility operated by Turquoise Global Holdings Limited, CHI-X and BATS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFIAFFLFLIE
Date   Source Headline
24th May 20219:30 amRNSDisclosure of director's details
18th May 20219:30 amRNSDirector/PDMR Shareholding
13th May 20212:46 pmRNSNotice of Results
13th May 20219:35 amRNSUpdate on Prudential Board Appointments
13th May 20219:30 amRNSBusiness and Jackson demerger update for 2021 AGM
12th May 20219:30 amRNSDirector/PDMR Shareholding
7th May 20219:30 amRNSPrudential announces 'net zero' asset owner pledge
4th May 20219:30 amRNSTotal Voting Rights
4th May 20219:30 amRNSDividend conversion rate achieved
30th Apr 20211:14 pmRNSUpdate on Jackson & Prudential Board appointments
14th Apr 20219:30 amRNSDirector/PDMR Shareholding
12th Apr 20213:26 pmRNSNotice of Annual General Meeting 2021
12th Apr 20219:30 amRNSDirector/PDMR Shareholding
1st Apr 20219:10 amRNSTotal Voting Rights
26th Mar 20219:17 amRNSDirector/PDMR Shareholding
23rd Mar 20217:00 amRNSFiling of Form 10 Registration Statement
19th Mar 20219:00 amRNSBlock Listing Application
18th Mar 20218:30 amRNSPrudential appoints new Non-Executive Director
16th Mar 202112:32 pmRNSPublication of Supplementary Prospectus
15th Mar 202111:21 amRNSAnnual Report and Accounts 2020 and Form 20-F
11th Mar 20219:30 amRNSDirector/PDMR Shareholding
9th Mar 20219:30 amRNSDirector/PDMR Shareholding
3rd Mar 20218:45 amRNS2020 Second Interim Dividend
3rd Mar 20218:39 amRNSPrudential Vietnam expands partnership with MSB
3rd Mar 20218:30 amRNSPrudential plc – FY20 Results – Risk Factors
3rd Mar 20218:30 amRNSPrudential plc – FY20 Results – EEV
3rd Mar 20218:30 amRNSPrudential plc – FY20 Results – IFRS
3rd Mar 20218:30 amRNSPrudential plc – FY20 Results – Business Review
1st Mar 20219:30 amRNSTotal Voting Rights
11th Feb 20219:30 amRNSDirector/PDMR Shareholding
11th Feb 20217:00 amRNSPrudential plc - Update on leadership of Jackson
10th Feb 202110:00 amRNSDirector/PDMR Shareholding
4th Feb 20218:30 amRNSBoard and Committee Changes
1st Feb 202110:00 amRNSTotal Voting Rights
28th Jan 20218:34 amRNSPrudential plc - Update on separation of Jackson
12th Jan 202112:00 pmRNSDirector/PDMR Shareholding
11th Jan 20212:00 pmRNSDirector/PDMR Shareholding
4th Jan 202112:00 pmRNSTotal Voting Rights
11th Dec 202010:00 amRNSDirector/PDMR Shareholding
9th Dec 202011:30 amRNSDirector/PDMR Shareholding
3rd Dec 20201:00 pmRNSChair succession effective 1 January 2021
1st Dec 202010:00 amRNSTotal Voting Rights
30th Nov 20204:41 pmRNSSecond Price Monitoring Extn
30th Nov 20204:37 pmRNSPrice Monitoring Extension
24th Nov 20209:00 amRNSSix monthly blocklisting
12th Nov 20209:00 amRNSBlocklisting
11th Nov 202010:00 amRNSDirector/PDMR Shareholding
10th Nov 202010:45 amRNSDirector/PDMR Shareholding
10th Nov 20209:00 amRNSDirector/PDMR Shareholding
2nd Nov 202010:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.